Analyst Reco. GSK plc

Equities

Market Closed - London S.E. Other stock markets 11:35:18 2024-10-09 am EDT			5-day change	1st Jan Change
1,458.00 ^GBX	+0.34%		-2.51%	+0.54%

06:23am	GSK Reaches $2.2 Billion Settlement for Majority of US Zantac Cases	MT
Oct. 09	Health Care Cos Up as Traders Hedge on Growth Views -- Health Care Roundup	DJ

GSK : JP Morgan reiterates its Sell rating	Oct. 09	ZD
GSK : Deutsche Bank gives a Buy rating	Oct. 09	ZD
GSK : Goldman Sachs remains Neutral	Oct. 09	ZD
GSK : Jefferies gives a Buy rating	Oct. 08	ZD
GSK : Goldman Sachs remains Neutral	Oct. 03	ZD
GSK : Jefferies gives a Buy rating	Oct. 03	ZD
GSK : Sell rating from JP Morgan	Oct. 03	ZD
GSK : Jefferies reaffirms its Buy rating	Sep. 18	ZD
GSK : JP Morgan remains a Sell rating	Sep. 17	ZD
GSK PLC : Despite transitioning towards speciality pharma, GSK is trading at OTC prices	Sep. 16
GSK : Goldman Sachs gives a Neutral rating	Sep. 16	ZD
GSK : Goldman Sachs reaffirms its Neutral rating	Sep. 13	ZD
GSK : Gets a Neutral rating from Goldman Sachs	Sep. 11	ZD
GSK : Goldman Sachs sticks Neutral	Sep. 10	ZD
GSK : Gets a Buy rating from Deutsche Bank	Sep. 09	ZD
GSK : Goldman Sachs reaffirms its Neutral rating	Aug. 16	ZD
GSK : Berenberg maintains buy recommendation, target 1820 pence	Aug. 15	CF
GSK : Gets a Buy rating from Berenberg	Aug. 15	ZD
GSK : Goldman Sachs gives a Neutral rating	Aug. 02	ZD
GSK : JP Morgan reiterates its Sell rating	Aug. 02	ZD

No results for this search

GSK PLC : Despite transitioning towards speciality pharma, GSK is trading at OTC prices

September 16, 2024 at 10:04 am EDT

Emma Walmsley, CEO of GSK: Antimicrobial resistance, a public health issue

GSK plc : Back on track

May 03, 2024 at 05:17 am EDT